CMT causes progressive muscle weakness and sensory loss. Moticon’s sensor insoles allow for monitoring of gait speed and foot drop (swing time). This provides neurologists with a sensitive “digital biomarker” to track disease progression or the efficacy of new drugs better than a 6-month checkup.